{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-261204","form_type":"8-K","ticker":"HCA","cik":"0000860730","company_name":"HCA Healthcare, Inc.","filed_at":"2023-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.176292+00:00","generated_at":"2026-06-09T15:34:36.196825+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"HCA Healthcare Q3 revenue $16.21B, EPS $3.91; FY 2023 guidance revised; dividend $0.60","bullets":["Revenue $16.213B (+8.3% YoY); net income $1.079B ($3.91 diluted EPS, flat vs $3.91 prior year).","Adjusted EBITDA $2.88B, down from $2.902B; same-facility admissions +3.4%, equivalent admissions +4.1%.","FY 2023 guidance revised: revenue $63.5-$64.5B, adjusted EBITDA $12.3-$12.6B, EPS $17.80-$18.50.","Board declared $0.60/share dividend payable Dec 28 to holders of record Dec 14; Q3 buyback $1.14B, $1.685B remaining.","CEO cited solid demand but Valesco physician staffing JV performed below expectations."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-261204","json":"https://secwatch.observer/filing/0001193125-23-261204.json","markdown":"https://secwatch.observer/filing/0001193125-23-261204.md","text":"https://secwatch.observer/filing/0001193125-23-261204.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/860730/000119312523261204/0001193125-23-261204-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/860730/000119312523261204/d551352d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T15:34:36.196825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2466734442f3a6a328f05ef8be9fd49ca7c2e3e5","claim":"HCA Healthcare, Inc. updated its year ending December 31, 2023 guidance (reaffirmed).","evidence_excerpt":"The 2023 guidance ranges for the year have been revised from our second quarter release as follows: Previous 2023 Guidance Range as of July 27, 2023 2023 Guidance Range as of October 24, 2023 Revenues $63.25 to $64.75 billion $63.5 to $64.5 billion Net Income Attributable to HCA Healthcare, Inc. $4.900 to $5.255 billion $4.940 to $5.130 billion Adjusted EBITDA $12.3 to $12.8 billion $12.3 to $12.6 billion EPS (diluted) $17.70 to $18.90 per diluted share $17.80 to $18.50 per diluted share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312523261204/0001193125-23-261204-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"year ending December 31, 2023"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"2811e6b5d4da7893b1513e07f8c74290429055e4","claim":"HCA Healthcare, Inc. reported third quarter ended September 30, 2023 results: revenue $16.213 billion, net income $1.079 billion, EPS $3.91 per diluted share.","evidence_excerpt":"results for the third quarter ended September 30, 2023. Key third quarter metrics (all percentage changes compare 3Q 2023 to 3Q 2022 unless otherwise noted): ● Revenues totaled $16.213 billion ● Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.91 per diluted share ● Adjusted EBITDA totaled $2.880 billion ● Cash flows from operating","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/860730/000119312523261204/0001193125-23-261204-index.htm","confidence":0.98,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2023"},{"label":"Revenue","value":"$16.213 billion"},{"label":"Net income","value":"$1.079 billion"},{"label":"EPS","value":"$3.91 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}